Back to Agenda
Bringing down barriers for access for gene and cell therapies in Europe
Session Chair(s)
Alexander Natz, JD
Secretary General
European Confederation of Pharmaceutical Entrepreneurs, Belgium
Innovative therapies can transform the lives of patients with severe and disabling diseases and revolutionise the way in which healthcare is delivered. However, national authorities and companies face multiple regulatory and financial challenges in providing access to these therapies. During this session, panellists will engage in a discussion to identify ways of ensuring a timely delivery of G&CTs to patients.
Speaker(s)
Panelist
Martina Schüssler-Lenz, DrMed
Paul-Erhlich-Institut, Germany
Deputy Head of ATMT; Chair, EMA Committee for Advanced Therapies
Panelist
Yann Le Cam, MBA
Eurordis-Rare Diseases Europe, France
Chief Executive Officer
Panelist
Francis Pang
Orchard Therapeutics, United Kingdom
SVP Global Market Access & Geographic Expansion
Have an account?